U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07364786) titled 'Effect of Salovum(R) on Pressure, Oxygen and Inflammation in Glioblastoma' on Oct. 08, 2024.
Brief Summary: The objective of this clinical trial is to investigate the effects of Salovum(R), an egg yolk powder enriched with the endogenous protein antisecretory factor, in participants undergoing diagnostic biopsies for suspected glioblastoma. The primary questions the trial seeks to answer are:
* Will Salovum(R) reduce intratumoral pressure?
* Will Salovum(R) influence the release of inflammatory cytokines from tumor tissue? Additionally, the study will investigate the impact of Salovum(R) on intratumoral partial oxygen pressure and...